The reason for obesity therapy to not to be a miracle cure for overweight individuals should be explained. Concept introduction: Leptin is AN acid amide created by fat cells in response to hormone and governs each intake habits and energy physiological state. a lot of specifically Leptin works by indicating the triglycerol level in adipocytes or fat cells to the central system. This dictates appetence. If a low quantity of Leptin is gift, then appetence will increase and contrariwise. The metabolism of fat is regulated by leptin that inhibits intake and promotes energy expenditure resulting in a rise in metastasis and therefore the inhibition of triacylglycerol production. Energy is lost as heat once Leptin facilitates the synthesis of uncoupling protein a pair of, that enters the mitochondria because the nucleon gradient. This energy isn't dispersed as heat and so not used for ATP production.

Question

Want to see the full answer?

Answer 1

Question

Chapter 27, Problem 13P

Interpretation Introduction

Interpretation:

The reason for obesity therapy to not to be a miracle cure for overweight individuals should be explained.

Concept introduction:

Leptin is AN acid amide created by fat cells in response to hormone and governs each intake habits and energy physiological state. a lot of specifically Leptin works by indicating the triglycerol level in adipocytes or fat cells to the central system. This dictates appetence. If a low quantity of Leptin is gift, then appetence will increase and contrariwise. The metabolism of fat is regulated by leptin that inhibits intake and promotes energy expenditure resulting in a rise in metastasis and therefore the inhibition of triacylglycerol production. Energy is lost as heat once Leptin facilitates the synthesis of uncoupling protein a pair of, that enters the mitochondria because the nucleon gradient. This energy isn't dispersed as heat and so not used for ATP production.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

When was the dihydropyridine calcium channel blocker isradipine first patented and by whom? Please provide information on the origin and history of isradipine and who owns it/manufactures it.

9) Below, there is a representation of an SDS-PAGE gel. Assuming the samples in the MW standard have masses of: 66 kDa, 45 kDa, 36 kDa, 29 kDa, 24 kDa, 20.1 kDa, and 14.2 kDa, a) Figure 4: indicate where each of the measurements were taken and label as in II.6. figure 2 above. b) As in II.7. Table 1 above create Table 2 using the data below. Determine the r.f. values for the MW standards, plot the relative mobility versus the log of the mass for the standards, and use the best fit straight line to determine the molecular weights of the proteins in the whey, peak 1, and peak 2 lanes. (5 pts—this will be scaled up appropriately if your gel did not develop properly) dye MW Whey Peak 1 Peak 2

what are the different classes and some examples of neuroprotectants that can be used to treat, prevent, or combat neurotoxicity/a neurotoxicant...for example, antioxidants, nutraceuticals, etc.,..?